Ae S. Youngpairoj - Concepedia

Author

Ae S. Youngpairoj

Centers for Disease Control and Prevention

Also Known As

A. S. Youngpairoj, Ae S Youngpairoj, Ae S. Youngpairoj, Ae Saekhou Youngpairoj, Ae Youngpairoj, Ae.S. Youngpairoj

Publications

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention National Center for Environmental Health Centers for Disease Control and Prevention

About

Ae S. Youngpairoj is an author at Centers for Disease Control and Prevention specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	411
2	Engineering	2	2	64
3	Public Health	2	2	113
4	Biochemistry	1	1	32
5	Biomedical Engineering	1	1	51

Ae S. Youngpairoj

Publications

997

Citations

H-Index

Page 1

	Year	Citations
Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection J. Gerardo Garcı́a-Lerma, Mian-er Cong, James Mitchell, Science Translational Medicine	2010	169
U.S. Human Immunodeficiency Virus Type 1 Epidemic: Date of Origin, Population History, and Characterization of Early Strains Kenneth E. Robbins, Philippe Lemey, Oliver G. Pybus, Journal of Virology	2003	117
Recombinant Viruses and Early Global HIV-1 Epidemic Marcia L. Kalish, Kenneth E. Robbins, Danuta Pieniążek, Emerging infectious diseases Viral EvolutionEmerging Infectious DiseasesMedicineGlobal HealthPathogenesis	2004	97
Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast Silvina Masciotra, Wei Luo, Ae S. Youngpairoj, Journal of Clinical Virology Ivory CoastTreatment And PreventionHuman RetrovirusHiv-2 Infected IndividualsHiv-1 Seroconverters	2013	75
High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients Silvina Masciotra, Ae S. Youngpairoj, Amanda McNulty, AIDS	2007	74
Natural Substrate Concentrations Can Modulate the Prophylactic Efficacy of Nucleotide HIV Reverse Transcriptase Inhibitors J. Gerardo Garcı́a-Lerma, Wutyi Aung, Mian-er Cong, Journal of Virology Prophylactic EfficacyMedicineHuman RetrovirusImmunologyAntiviral Response	2011	74
HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 C Ae S. Youngpairoj, Silvina Masciotra, Carmen Garrido, Journal of Antimicrobial Chemotherapy	2008	63
HIV Transmission in a State Prison System, 1988–2005 Krishna Jafa, Peter D. McElroy, Lisa Fitzpatrick, PLoS ONE	2009	55
Development and optimization of thermal contrast amplification lateral flow immunoassays for ultrasensitive HIV p24 protein detection Li Zhan, Timothy C. Granade, Yilin Liu, Microsystems & Nanoengineering EngineeringHuman RetrovirusBioanalysisImmunologyNucleic Acid Amplification Test	2020	51
Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3<sub>M184V</sub>Mutant by Intermittent Prophylaxis with Truvada Mian-er Cong, Ae S. Youngpairoj, Qi Zheng, Journal of Virology Ftc ResistanceImmunodeficienciesImmunologyAntiviral DrugIntermittent Prophylaxis	2011	40

Page 1